The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

After adjusting for potential confounders (age, sex, race, use of birth control, pregnancy), findings showed propranolol use was associated with a significant reduction in the risk of stroke among ...

Migraines affect millions worldwide, yet remain widely misunderstood. This neurological condition extends far beyond typical headache symptoms, often ...

A common drug used to prevent migraines might have an additional benefit -- protecting women against stroke.Women takin ...

A study published in The Lancet found that sodium nitrite provoked headaches in eight out of 13 people who consumed it.

Patti Smith will be dancing barefoot again soon. The 78-year-old rocker told her fans she’s “absolutely fine” after she experienced a “small incident” onstage while performing in Brazil on Wednesday.

The rocker returned to the stage in a wheelchair, and later told fans the incident "does not merit so much attention" ...

Patti Smith reportedly collapsed at a stage in Sao Paulo on January 29 but returned soon after to address the audience ...

A medication often used to treat high blood pressure and prevent migraines was associated with a reduction in ischemic stroke risk among women using the drug for migraine prevention, according to a ...

FDA approves Symbravo for acute migraine relief, combining rizatriptan and meloxicam. Discover its unique benefits and fast absorption for effective symptom control.

Anti-CGRP antibodies vs onabotulinumtoxinA is not associated with increased cardiovascular disease risk in older patients ...

A 2017 research review comparing side effect risks of migraine treatments found almotriptan had the highest risk of vomiting associated with use. Triptan medications may not be right for everyone.